Works matching IS 17574676 AND DT 2018 AND VI 10 AND IP 6

Results: 6

mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.
Published in:
EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201708262
By:
- Grady, John P.;
- Pickett, Sarah J.;
- Ng, Yi Shiau;
- Alston, Charlotte L.;
- Blakely, Emma L.;
- Hardy, Steven A.;
- Feeney, Catherine L.;
- Bright, Alexandra A.;
- Schaefer, Andrew M.;
- Gorman, Gráinne S.;
- McNally, Richard J. Q.;
- Taylor, Robert W.;
- Turnbull, Doug M.;
- McFarland, Robert
Publication type:
Article
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer.
Published in:
EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201707945
By:
- Tsui, Dana Wai Yi;
- Murtaza, Muhammed;
- Wong, Alvin Seng Cheong;
- Rueda, Oscar M.;
- Smith, Christopher G.;
- Chandrananda, Dineika;
- Soo, Ross A.;
- Lim, Hong Liang;
- Goh, Boon Cher;
- Caldas, Carlos;
- Forshew, Tim;
- Gale, Davina;
- Liu, Wei;
- Morris, James;
- Marass, Francesco;
- Eisen, Tim;
- Chin, Tan Min;
- Rosenfeld, Nitzan
Publication type:
Article
Enhancement of red blood cell transfusion compatibility using CRISPR‐mediated erythroblast gene editing.
Published in:
EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201708454
By:
- Hawksworth, Joseph;
- Satchwell, Timothy J.;
- Meinders, Marjolein;
- Daniels, Deborah E.;
- Regan, Fiona;
- Thornton, Nicole M.;
- Wilson, Marieangela C.;
- Dobbe, Johannes G. G.;
- Streekstra, Geert J.;
- Trakarnsanga, Kongtana;
- Heesom, Kate J.;
- Anstee, David J.;
- Frayne, Jan;
- Toye, Ashley M.
Publication type:
Article
Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability.
Published in:
EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201708289
By:
- Iwai, Kenichi;
- Yaguchi, Masahiro;
- Nishimura, Kazuho;
- Yamamoto, Yukiko;
- Tamura, Toshiya;
- Nakata, Daisuke;
- Dairiki, Ryo;
- Kawakita, Yoichi;
- Mizojiri, Ryo;
- Ito, Yoshiteru;
- Asano, Moriteru;
- Maezaki, Hironobu;
- Nakayama, Yusuke;
- Kaishima, Misato;
- Hayashi, Kozo;
- Teratani, Mika;
- Miyakawa, Shuichi;
- Iwatani, Misa;
- Miyamoto, Maki;
- Klein, Michael G.
Publication type:
Article
A novel CHCHD10 mutation implicates a Mia40‐dependent mitochondrial import deficit in ALS.
Published in:
EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201708558
By:
- Lehmer, Carina;
- Schludi, Martin H.;
- Ransom, Linnea;
- Greiling, Johanna;
- Junghänel, Michaela;
- Exner, Nicole;
- Riemenschneider, Henrick;
- van der Zee, Julie;
- Van Broeckhoven, Christine;
- Weydt, Patrick;
- Heneka, Michael T.;
- Edbauer, Dieter
Publication type:
Article
CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors.
Published in:
EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201809213
By:
- Salvador, Fernando;
- Gomis, Roger R.
Publication type:
Article

Works matching IS 17574676 AND DT 2018 AND VI 10 AND IP 6

mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer.

Enhancement of red blood cell transfusion compatibility using CRISPR‐mediated erythroblast gene editing.

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability.

A novel CHCHD10 mutation implicates a Mia40‐dependent mitochondrial import deficit in ALS.

CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors.